MedTrace Logo

MOVIPREP® Versus NaP Pivotal Phase III Study

NCT00322062 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 340

Last updated 2008-04-16

No results posted yet for this study

Summary

The aim of the study is to compare a new 2 litre bowel cleansing product versus a sodium phosphate solution already on the market. Efficacy of each bowel preparation, safety and acceptability will be assessed.

Conditions

  • Colonoscopy

Interventions

DRUG

macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate

2L gut lavage solution

DRUG

Sodium Phosphate Solution

1 x 45ml solution, BID

Sponsors & Collaborators

Principal Investigators

  • Alain Bitoun, MD · Hôpital Lariboisère

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-04-30
Completion
2003-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00322062 on ClinicalTrials.gov